Chinese medicine to delay kidney failure in diabetic kidney disease
Part of Hormones & metabolism, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study tests a traditional Chinese medicine treatment approach to delay the progression of diabetic kidney disease to end-stage kidney failure. It may help people with type 2 diabetes who already have kidney damage and are looking to protect their kidneys.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have type 2 diabetes that has caused kidney problems.
- You are between 18 and 80 years old.
- Your kidney function is above a certain level (eGFR greater than 15).
- You have not been diagnosed with other kidney diseases like polycystic kidney disease or glomerulonephritis.
- You do not have type 1 diabetes.
- You have no history of frequent urinary tract infections.
- You are not pregnant, planning to become pregnant, or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a traditional Chinese medicine approach to slow down kidney damage in people with diabetic kidney disease. It aims to delay the need for dialysis or a kidney transplant.
This study tests whether a goal-directed treatment plan using several medications can lower the risk of kidney and heart problems for people with diabetes and kidney disease. It aims to help you manage your condition more effectively.
This trial tests a medication, finerenone, to help protect kidney function and prevent heart failure in people with type 2 diabetes and chronic kidney disease. If you have diabetes and kidney problems, this medicine might slow down further kidney damage.
This trial tests an oral Chinese herbal capsule (Naoxintong) added to your usual care to see if it can better protect your kidneys from diabetic kidney disease. You will have a 50/50 chance of getting the real capsule or a placebo (no active ingredient).
This trial focuses on improving how kidney damage is diagnosed and how treatment is planned for people with type 2 diabetes and kidney disease. It may help by using detailed medical history and (if done) kidney biopsy results to guide care more accurately.
This trial tests a new system to manage diabetic kidney disease across all stages. It is for people with type 2 diabetes who either have no kidney damage or have kidney damage confirmed by a biopsy.
Hear when a new Diabetic Kidney Disease (DKD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.